Fri, July 28, 2023
Thu, July 27, 2023
Wed, July 26, 2023

Andrew Fein Reiterated (AMLX) at Strong Buy and Held Target at $50 on, Jul 27th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-50-on-jul-27th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Reiterated "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy and Held Target at $50 on, Jul 27th, 2023.

Andrew has made no other calls on AMLX in the last 4 months.



There are 2 other peers that have a rating on AMLX. Out of the 2 peers that are also analyzing AMLX, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Chris Shibutani of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $49 on, Monday, July 24th, 2023
  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $50 on, Monday, May 15th, 2023

Publication Contributing Sources